SMITH IAN F 4
4 · Stoke Therapeutics, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
SMITH IAN F
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-20+238,420→ 238,420 totalExercise: $8.33Exp: 2035-03-19→ Common Stock (238,420 underlying)
Footnotes (1)
- [F1]The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.